Unrivaled Brands (UNRV)

Overall impact
C (55)

Commentary

Unrivaled Brands is an average overall performer. With a 'C' rating of 55.3 for overall impact (52nd percentile compared to all companies), Unrivaled Brands ranks 123rd out of 154 industry peers, behind Adamis Pharmaceuticals, Benitec Biopharma, Aquinox Pharmaceuticals and 119 others, and ahead of Evolus, Organogenesis, Mayne Pharma and 28 others. On top material causes for Unrivaled Brands's industry (Pharmaceuticals & Biotech), Unrivaled Brands performs well in Humane Treatment of Animals (83.5 score), Sustainable Use of Water (95.6), Reduced Use of tobacco (87.6) and 1 other cause where it received an 'A' score and performs poorly in Access to Affordable Healthcare (36.6 score), Reduced Green House Gas Emissions (20.6), Disease Eradication (32.1) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause UNRV
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
151
Sector
Industrials
Industry
Machinery
Sub-industry
Industrial Machinery & Supplies & Components
SASB industry
Biotechnology & Pharmaceuticals
Headquarters
Ca, United States
Share classes
UNRV
Description
Unrivaled Brands, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California, Oregon, and Nevada. It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities. The company was formerly known as Terra Tech Corp. and changed its name to Unrivaled Brands, Inc. in July 2021. Unrivaled Brands, Inc. was founded in 2010 and is based in Santa Ana, California.
Material causes
Ethos considers the following causes material for Unrivaled Brands, based on its industry sub-industry Industrial Machinery & Supplies & Components. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.